Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain.

Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff FA, Booij J.

Neuropsychopharmacology. 2002 Mar;26(3):387-96.

2.

Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission.

Reneman L, Booij J, Schmand B, van den Brink W, Gunning B.

Psychopharmacology (Berl). 2000 Feb;148(3):322-4.

PMID:
10755746
3.

MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings.

Reneman L, Habraken JB, Majoie CB, Booij J, den Heeten GJ.

AJNR Am J Neuroradiol. 2000 Jun-Jul;21(6):1001-7.

4.

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings.

Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J.

Arch Gen Psychiatry. 2001 Oct;58(10):901-6.

PMID:
11576026
6.

Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.

Urban NB, Girgis RR, Talbot PS, Kegeles LS, Xu X, Frankle WG, Hart CL, Slifstein M, Abi-Dargham A, Laruelle M.

Neuropsychopharmacology. 2012 May;37(6):1465-73. doi: 10.1038/npp.2011.332. Epub 2012 Feb 22.

7.

Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.

Di Iorio CR, Watkins TJ, Dietrich MS, Cao A, Blackford JU, Rogers B, Ansari MS, Baldwin RM, Li R, Kessler RM, Salomon RM, Benningfield M, Cowan RL.

Arch Gen Psychiatry. 2012 Apr;69(4):399-409. doi: 10.1001/archgenpsychiatry.2011.156. Epub 2011 Dec 5.

8.

Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA].

Ross JD, Herin DV, Frankel PS, Thomas ML, Cunningham KA.

Drug Alcohol Depend. 2006 Feb 1;81(2):117-27. Epub 2005 Jul 28.

PMID:
16054778
9.
10.

Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons.

Capela JP, Fernandes E, Remião F, Bastos ML, Meisel A, Carvalho F.

Neurotoxicology. 2007 Jul;28(4):868-75. Epub 2007 Apr 27.

PMID:
17572501
11.

Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.

Sanchez V, O'shea E, Saadat KS, Elliott JM, Colado MI, Green AR.

J Psychopharmacol. 2004 Sep;18(3):412-6.

PMID:
15358986
12.

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.

Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W.

Lancet. 2001 Dec 1;358(9296):1864-9.

PMID:
11741626
13.

Decreased 5-HT2a receptor binding in patients with anorexia nervosa.

Audenaert K, Van Laere K, Dumont F, Vervaet M, Goethals I, Slegers G, Mertens J, van Heeringen C, Dierckx RA.

J Nucl Med. 2003 Feb;44(2):163-9.

14.

Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density.

McGregor IS, Clemens KJ, Van der Plasse G, Li KM, Hunt GE, Chen F, Lawrence AJ.

Neuropsychopharmacology. 2003 Aug;28(8):1472-84. Epub 2003 Apr 16.

15.

Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.

Jones K, Brennan KA, Colussi-Mas J, Schenk S.

Addict Biol. 2010 Jul;15(3):289-98. doi: 10.1111/j.1369-1600.2010.00217.x. Epub 2010 May 11.

PMID:
20477756
17.

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.

Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR.

Br J Pharmacol. 2002 Jan;135(1):170-80.

18.

Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI.

Schouw ML, Gevers S, Caan MW, Majoie CB, Booij J, Nederveen AJ, Reneman L.

Eur Neuropsychopharmacol. 2012 Aug;22(8):537-45. doi: 10.1016/j.euroneuro.2011.12.002. Epub 2011 Dec 29.

20.

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.

Liechti ME, Saur MR, Gamma A, Hell D, Vollenweider FX.

Neuropsychopharmacology. 2000 Oct;23(4):396-404.

Items per page

Supplemental Content

Write to the Help Desk